DOMH Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Stats
Today's Volume	4 603.00
Average Volume	12 645.00
Market Cap	12.70M
EPS	$0 ( 2024-05-09 )
Next earnings date	( $0 ) 2024-08-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.490
ATR14	$0.0700 (3.27%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-08	Wool Kyle Michael	Buy	4 250	Common Stock
2024-04-08	Wool Kyle Michael	Buy	4 250	Common Stock
2024-04-04	Wool Kyle Michael	Buy	9 500	Common Stock
2024-04-04	Wool Kyle Michael	Buy	9 500	Common Stock
2024-04-05	Hayes Anthony	Buy	13 500	Common Stock

INSIDER POWER
100.00
Last 58 transactions
Buy: 1 513 198 \| Sell: 0

Dominari Holdings Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Dominari Holdings Inc. Financials

Annual	2023
Revenue:	$2.04M
Gross Profit:	$1.60M (78.32 %)
EPS:	$-4.38

FY	2023
Revenue:	$2.04M
Gross Profit:	$1.60M (78.32 %)
EPS:	$-4.38

FY	2022
Revenue:	$0
Gross Profit:	$188 000 (0.00 %)
EPS:	$-7.23

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.530

Financial Reports:

No articles found.

Dominari Holdings Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Dominari Holdings Inc.

Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.